Viridian Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Viridian Therapeutics has a total shareholder equity of $529.3M and total debt of $20.5M, which brings its debt-to-equity ratio to 3.9%. Its total assets and total liabilities are $585.7M and $56.3M respectively.
Key information
3.9%
Debt to equity ratio
US$20.45m
Debt
| Interest coverage ratio | n/a |
| Cash | US$571.37m |
| Equity | US$529.34m |
| Total liabilities | US$56.33m |
| Total assets | US$585.66m |
Recent financial health updates
Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Sep 11
Is Viridian Therapeutics (NASDAQ:VRDN) Using Debt Sensibly?
May 28Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt
Sep 12Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Apr 18Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Jan 08Recent updates
Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Sep 11Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way
Sep 10Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
Jun 12Is Viridian Therapeutics (NASDAQ:VRDN) Using Debt Sensibly?
May 28Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt
Sep 12Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?
May 15Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Apr 18Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Jan 08Viridian: Excellent Early Data, Strong Cash, Great Strategy, Large Market
Sep 09Viridian Therapeutics board compensation committee approves inducement grants
Sep 02An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued
Aug 22Viridian Therapeutics Q2 2022 Earnings Preview
Aug 12Financial Position Analysis
Short Term Liabilities: VRDN's short term assets ($581.7M) exceed its short term liabilities ($36.8M).
Long Term Liabilities: VRDN's short term assets ($581.7M) exceed its long term liabilities ($19.6M).
Debt to Equity History and Analysis
Debt Level: VRDN has more cash than its total debt.
Reducing Debt: VRDN's debt to equity ratio has reduced from 30.4% to 3.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VRDN has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: VRDN has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 37.2% each year.